|Home | About | Journals | Submit | Contact Us | Français|
Calcium signaling is studied as a potential form of astrocyte excitability that may control astrocyte involvement in synaptic and cerebrovascular regulation. Fundamental questions remain unanswered about astrocyte calcium signaling, as current methods can not resolve calcium in small volume compartments, such as near the cell membrane and in distal cell processes. We modified the genetically encoded calcium sensor GCaMP2 with a membrane-tethering domain, Lck, increasing the level of Lck-GCaMP2 near the plasma membrane tenfold as compared with conventional GCaMP2. Using Lck-GCaMP2 in rat hippocampal astrocyte-neuron cocultures, we measured near-membrane calcium signals that were evoked pharmacologically or by single action potential–mediated neurotransmitter release. Moreover, we identified highly localized and frequent spontaneous calcium signals in astrocyte somata and processes that conventional GCaMP2 failed to detect. Lck-GCaMP2 acts as a genetically targeted calcium sensor for monitoring calcium signals in previously inaccessible parts of astrocytes, including fine processes.
Astrocytes tile the CNS, exert essential support functions1, provide energy metabolites to neurons2, and respond to injury and disease3. In addition, evidence suggests that astrocytes participate in synaptic function4 and regulate blood flow to meet demands set by neuronal activity5,6. The combination of timescale and cellular architecture involved in these responses suggests that certain astrocyte functions are regulated by rapid signaling events in distal processes that contact synapses or blood vessels.
Astrocytes display excitability in the form of intracellular calcium concentration increases that have been recorded in vitro7, in vivo8–13 and in brain slices from humans14. Astrocyte calcium transients occur spontaneously and are increased by neuronal activity15. As calcium is a ubiquitous second messenger, astrocyte calcium elevations may control communication with other cells. Communication between astrocytes and neurons is particularly intriguing because individual astrocytes contact many thousands of synapses16,17 and because electrophysiological and imaging studies demonstrate the synaptic consequences of second messenger signaling in astrocyte processes18.
Physiological experiments suggest two settings in which astrocytes and neurons may communicate. First, calcium levels in astrocytes are elevated in response to neurotransmitters released from neurons19. Second, increases in astrocyte calcium cause the release of glutamate, which in turn affects neurons20,21. These data suggest that calcium-dependent ‘gliotransmitter’ release leads to short- and long-term changes in neuronal and synaptic function18,22. Nevertheless, calcium-dependent astrocyte-to-neuron signaling is still debated and there is evidence both for20,21,23,24 and against it25,26 being a prevalent feature of CNS circuits. These issues have been discussed extensively15,27–30, raising awareness of the need for improved methods to selectively activate, silence and monitor astrocyte calcium signals.
Recent work has suggested that somatic calcium signals may be an unreliable measure of astrocyte excitability and its downstream signaling31. The controversy on the role of astrocyte calcium signals in influencing neuronal function may also be rooted in the fact that most experimental evidence stems from calcium measurements in somatic compartments, which is paradoxical when one considers that astrocytes are thought to signal at a local level via their distal processes18,29. This situation exists because current methods can not measure calcium in small volume compartments such as astrocyte processes, which are too meager to adequately load with organic calcium indicator dyes29, although pioneering attempts have found distributed glial calcium signaling32,33.
A direct method for monitoring calcium signals in astrocyte processes is needed to elucidate if, when, where and how astrocytes affect neurons. Buoyed by recent advances using genetic targeting to achieve selective astrocyte ablation34, silencing of exocytosis35, as well as blockade26 and activation25 of astrocyte calcium signals, we developed a genetic strategy for monitoring real-time astrocyte calcium signaling selectively in near-membrane regions and processes.
Protoplasmic astrocytes are known to have fine branches in vivo and it is thought that they signal locally in processes29. One problem in the study of astrocyte calcium signaling has been the inability to measure calcium in astrocyte processes with organic calcium indicator dyes29. Moreover, it is commonly assumed that a change in astrocyte calcium measured globally reflects similar changes near the plasma membrane, although this has not been directly investigated.
Using rat hippocampal astrocyte-neuron cocultures, we studied spontaneous astrocyte calcium transients with epifluorescence (EPI) and total internal reflection fluorescence (TIRF) microscopy36, which measure global and near-membrane calcium signals, respectively36 (Fig. 1a). We observed that 48% of 211 calcium transients (from 33 astrocytes) measured globally also elevated calcium near the plasma membrane in 10 ms; we referred to these as synchronized events. This was readily visible by subtracting the normalized EPI and TIRF traces, resulting in a flat trace (Fig. 1b). However, 50% of 211 calcium transients measured globally failed to elevate calcium near the plasma membrane; we referred to these as EPI unique events and the cells in which they occurred as being partially synchronized (Fig. 1c). A further 2% of 211 events only elevated calcium near the plasma membrane (these were not examined further). In contrast with the differences observed for spontaneous calcium signals, application of 30 µM ATP to activate astrocyte P2Y1 receptors increased calcium globally and near the membrane (Fig. 1b,c). On average, the EPI unique events were smaller and briefer than the synchronous ones (dF/F values of 5 ± 4 and 30 ± 6% and half duration values of 5.4 ± 0.9 and 8.4 ± 1.0 s for EPI unique and synchronous events, respectively). Using ratiometric Fura-2 imaging37, we estimated the change in cytosolic calcium concentration in three different conditions (Fig. 2a,b), spontaneous calcium signals (n = 50) and for signals evoked by 1 and 30 µM ATP (n = 65 and 103, respectively). We then repeated these experiments using Fluo-4 and measured dF/F values for spontaneous and 1 and 30 µM ATP-evoked calcium signals (n = 207, 18 and 56, respectively). Using both datasets, we determined a proportionality constant between the Fluo-4 and Fura-2 signals and used this to estimate the change in calcium concentration. Thus, synchronous events elevated calcium in the cytosol by ~300–400 nM, whereas EPI unique events elevated calcium in the cytosol by less than ~100 nM.
We examined the ability of G protein–coupled receptor (GPCR) agonists to elevate calcium globally and near the membrane of astrocytes. We used ATP (30 µM), glutamate (300 µM), DHPG (10 µM), TFLLR (30 µM) and ET-1 (100 nM), which are agonists of P2Y1, mGluR, group I mGluR, PAR-1 and endothelin-1 receptors, respectively. We also used FLRFa (5 µM) as an agonist of heterologously expressed MrgA1 receptors25. In each case, the GPCR agonists elevated calcium levels globally and near the membrane with similar kinetics. Taken together, these experiments suggest that global measures of spontaneous astrocyte calcium transients do not accurately reflect calcium dynamics near the membrane and GPCR agonists do not mimic spontaneous astrocyte calcium signals in terms of amplitude (Fig. 2c) or spread to the plasma membrane (Fig. 2). We sought to develop an approach for measuring calcium in small volumes of astrocytes such as near the membrane and in fine processes.
GCaMP2 is a genetically encoded green fluorescent protein (GFP)-based calcium indicator that increases its fluorescence yield when calcium ions bind to the M13 and CaM fragments38,39 (Fig. 3a). We used GCaMP2 because it is excited and emits at a single wavelength (488 and 508 nm, respectively) and has a calcium affinity of ~150 nM, close to that of organic calcium indicator dyes that have been used in past studies of astrocyte calcium signaling29. In addition, GCaMP2 kinetics are suited to astrocytes, which have transients that exist on a timescale of seconds15 (Figs. 1 and and22).
We expressed GCaMP2 in astrocytes to determine whether we could measure spontaneous calcium transients. GCaMP2 was robustly expressed in astrocytes (Supplementary Video 1), but we failed to detect any spontaneous calcium transients in eight of eight cells with EPI or TIRF microscopy (imaged for 5 min each; Supplementary Video 1). We could, however, measure calcium elevations triggered by bath applications of GPCR agonists in all cells (for example, 30 µM ATP; Supplementary Video 2). From these data, we concluded that cytosolic GCaMP2 was not suitable for monitoring spontaneous astrocyte calcium transients.
One way to improve GCaMP2 is to optimize it through mutagenesis, but another approach is to target GCaMP2 to the plasma membrane, effectively increasing its local expression in a restricted volume. This should improve the signal-to-noise ratio, as the reporter would be in the plane of the membrane in which calcium fluxes may be maximal. Cognizant of previous experiences with membrane tethers40, we used the N-terminal domain of Lck, a Src tyrosine kinase, which is known to contain tandem palmitoylation and myristoylation domains41,42.
We engineered GCaMP2 to carry the N-terminal 26 residue tag that we refer to as the Lck domain to generate Lck-GCaMP2 (Fig. 3a), burying an N-terminal arginine residue that could render GCaMP2 susceptible to degradation43. For initial expression analysis and characterization, we expressed Lck-GCaMP2 in HEK-293 cells (Fig. 3). In contrast with the cytosolic fluorescence of GCaMP2 (Fig. 3b), we observed fluorescence that was localized to the edges of cells with Lck-GCaMP2 (Fig. 3c). Lck-GCaMP2 also provided fluorescence measurements of calcium ion concentration with a Ca2+ Kd of 168 ± 27 nM and Hill slope of 4.0 ± 1.0 (n = 9; Fig. 3d), close to reported values for GCaMP2 (ref. 39).
We expressed Lck-GCaMP2 in astrocytes and determined whether it was uniformly expressed in the membrane (Supplementary Fig. 1) by comparing TIRF images of astrocytes expressing Lck-GCaMP2 to those of cells expressing Lck-GFP and to astrocytes labeled with the membrane dye FM1-43. In all three cases, the TIRF images were similar, with no obvious puncta (Supplementary Fig. 1), indicating that Lck-GCaMP2 was uniformly distributed in the membrane.
We determined whether Lck-GCaMP2 could measure GPCR activation in astrocytes using ATP as a P2Y1 agonist (Figs. 1, ,22 and and4a)4a) by employing rapid switching44 between TIRF and EPI to compare the signals measured globally and near the membrane of astrocytes expressing Lck-GCaMP2. We found that the ATP–evoked calcium signals measured with EPI and TIRF microscopy were almost identical in their time course (Fig. 4b) and that the signals had the same ATP sensitivity, with half-maximal effective concentration (EC50) values of ~2 µM (EPI, 1.6 ± 0.2 µM; TIRF, 1.9 ± 0.2 µM; n = 10) and Hill slopes of ~2.6 (EPI, 2.6 ± 0.3; TIRF, 2.3 ± 0.1; n = 10; Fig. 4b,c). These values are similar to the ATP EC50 of 3.5 µM (n = 28–54) measured with Fluo-4 (Fig. 4d).
We used hippocampal astrocyte-neuron cocultures to determine whether Lck-GCaMP2 could measure signaling mediated by neuro-transmitter release from neurons onto astrocytes29. We applied 1–180 action potentials at 30 Hz using electrical field stimulation (EFS) and plotted the change in fluorescence measured from astrocytes expressing Lck-GCaMP2 using EPI microscopy (Fig. 5a,b). The peak dF/F was related to the number of action potentials between 1 and 60. In 7 of 11 astrocytes, a single action potential caused substantial increases in Lck-GCaMP2 fluorescence (0.37 ± 0.09, n = 7), which lasted 19.2 ± 4.8 s (quantified as T0.5). The EFS-evoked signals were reproducible when EFS was applied every 5 min (Fig. 5).
We repeated the EFS experiments with tetrodotoxin (TTX, 1 µM, n = 5) or Cd2+ (100 µM, n = 5) in the bath solution to block voltage-dependent sodium and calcium channels, respectively, and found that the EFS-evoked fluorescence changes were abolished (Fig. 5c–e). On the basis of previous findings45, we examined whether ATP was released during EFS from neurons to mediate calcium signals in astrocytes. PPADS, a broad spectrum P2Y receptor antagonist, completely abolished the EFS-evoked signals (30 µM, n = 5; Fig. 5e). This is consistent with previous results on the functional expression of P2Y1 receptors in astrocytes29. Consistent with this, the P2Y1 receptor antagonist MRS2179 substantially decreased the responses evoked by EFS by ~40% (20 µM, n = 10; Fig. 5e). Moreover, the EFS-evoked responses were abolished when intracellular calcium stores were depleted with cyclopiazonic acid (CPA, 20 µM, n = 4).
In contrast with cytosolic GCaMP2 (Supplementary Video 1), we readily monitored spontaneous astrocyte calcium transients using Lck-GCaMP2 and EPI microscopy. We observed numerous brief and spotty calcium signals in astrocytes, events that we referred to as microdomains (Fig. 6a,b and Supplementary Videos 3 and 4). By marking the area covered by each microdomain over 2 min of recording (Fig. 6a), we determined that they covered 23 ± 8% (n = 8) of the astrocyte surface. Microdomains occurred randomly, independently of each other, repeatedly at the same location and displayed kinetics on a timescale of seconds (Fig. 6c). The somatic microdomains had a full-width half maxima (FWHM) of 5.1 ± 0.1 µm (n = 6), greater than the point spread function of our microscope (~0.4 µm; Fig. 6d).
Many microdomains (~80%) were in astrocyte cell bodies, with the remainder being present in astrocyte processes that extended >20 µm (Fig. 7a). These latter microdomains were spatially and temporally distinct from somatic events (Fig. 7a), but we found no substantial differences between microdomains in somata and processes in terms of dF/F, T0.5 and frequency (Supplementary Table 1). On average, we recorded 4.1 ± 1.6 microdomain locations per astrocyte (n = 8), with a mean T0.5 of 3.9 ± 0.3 s (n = 408), a peak dF/F of 0.50 ± 0.01 (n = 515) and a frequency of 0.8 ± 0.07 events min−1 (159 microdomains, 56 cells).
Astrocytes in culture are flat, whereas they are more branched in situ. To recapitulate this more elaborate morphology, we treated the cells with 5 mM db-cAMP for 48 h, as this is known to cause astrocytes to extend processes46 (Supplementary Fig. 2 and Supplementary Video 5). We readily detected spontaneous Lck-GCaMP2 fluorescence increases in these extended processes that were very similar to those in cells that were not treated with db-cAMP (Fig. 7b and Supplementary Table 1). The spontaneous signals occurred up to 86 µm from the astrocyte cell body with a mean distance of 39 ± 5 µm (n = 22; Fig. 7b). This is consistent with the length of astrocyte processes found in situ, between 17–51 µm47, indicating that Lck-GCaMP2 can report localized calcium signals in processes that are similar in length to those in intact preparations (Fig. 7b and Supplementary Table 1).
In contrast with the EFS-evoked signals (Fig. 5), microdomains were insensitive to 1 µM TTX (n = 6; Fig. 8a). We also found that CPA (20 µM, n = 12) completely abolished ATP-evoked calcium transients (Fig. 8) but spared the microdomains (n = 21) measured with Lck-GCaMP2 (Fig. 8b,d). Conversely, we found that microdomains were abolished in calcium-free extracellular buffers (n = 20), whereas the ATP-evoked responses persisted (n = 10; Fig. 8c,d). Moreover, incubation with the ATP receptor antagonist PPADS abolished ATP-evoked signals (n = 11) but had no effect on microdomains (10 µM, n = 16; Fig. 8d). Finally, activation of P2Y1 and PAR1 GPCRs, alone or together, robustly elevated global calcium levels31, but failed to affect the frequency of microdomain calcium signals (Supplementary Fig. 3). Taken together, these experiments provide strong evidence that microdomain calcium signals are independent of GPCR activation and calcium release from intracellular stores but are dependent on transmembrane calcium fluxes. Our data clearly show that Lck-GCaMP2 can be used to non-invasively monitor global (Fig. 4), pharmacologically evoked (Fig. 4), electrically evoked (Fig. 5) and spontaneous calcium signals in astrocytes (Figs. 6–8).
We imaged Lck-GCaMP2-expressing hippocampal neurons to determine whether astrocyte microdomain calcium signals were cell specific (Supplementary Fig. 4 and Supplementary Table 1) and found several similarities and differences between neurons and astrocytes. First, ATP failed to evoke calcium signals in neurons but did so in astrocytes. In contrast, glutamate evoked similar signals in neurons and astrocytes (Supplementary Fig. 4 and Supplementary Table 1). Second, we did not detect any spontaneous microdomains in nine of ten neurons (Supplementary Fig. 4, Supplementary Video 6 and Supplementary Table 1), whereas we were readily able to observe microdomains in astrocytes (Supplementary Table 1). Third, where spontaneous calcium signals were detected (one of ten neurons), they were abolished by 1 µM TTX. In contrast, microdomains in astrocytes were resistant to TTX (Fig. 8). Fourth, Lck-GCaMP2 was equally well expressed in neurons and astrocytes (Supplementary Table 1). Overall, our data indicate that microdomain calcium signals recorded in astrocytes with Lck-GCaMP2 are unlike signals measured in neurons.
Given that astrocytes in culture have intracellular vesicles and given that application of Lck-GCaMP2 results in uniform labeling of the plasma membrane (Supplementary Fig. 1), we next determined whether movement of fluorescent vesicles into a region of interest (ROI) could account for microdomain calcium signals (Supplementary Fig. 5). First, the microdomains were abolished by removing extracellular calcium (Fig. 8), which is strong evidence for transmembrane calcium fluxes rather than vesicle movement. Second, using Lck-GFP, the dF/F values resulting from vesicle movement into an ROI were tenfold smaller than dF/F values for microdomains measured with Lck-GCaMP2 (Supplementary Fig. 5 and Supplementary Video 7). Third, the FWHM of Lck-GFP-labeled vesicles was at the resolution of our microscope at ~400 nm (Supplementary Fig. 5), whereas microdomains displayed FWHM of ~5 µm (Fig. 6d). Thus, vesicle movement can not account for the microdomain calcium signals measured with Lck-GCaMP2.
We also considered the possibility that the astrocyte membrane may be tortuous, leading to more Lck-GCaMP2 in spots, which may, in turn, lead to more robust calcium signals in these areas. We measured the fluorescence intensity of ROIs encompassing microdomains before they occurred and compared these values with those of the two nearest ROIs (2 and 5 µm away; Supplementary Fig. 6). We found that the basal fluorescence intensity of Lck-GCaMP2 was not different from that of the nearest ROIs that did not display microdomains. Within the limits of resolution, these data suggest that microdomain calcium signals are not a result of local accumulation of Lck-GCaMP2 (Supplementary Fig. 6).
We further characterized Lck-GCaMP2 expression in astrocytes (Supplementary Fig. 7). First, we found that Lck-GCaMP2 was mainly expressed in the plasma membrane (Supplementary Fig. 7), where it was ~14-fold more abundant than GCaMP2 (Supplementary Fig. 7). Second, the mobility of Lck-GCaMP2 was substantially lower than that of cytosolic GCaMP2 (Supplementary Fig. 7). Thus, our results suggest that high plasma membrane expression of a slowly diffusible indicator renders Lck-GCaMP2 well suited to measure localized spontaneous microdomain calcium signals near the membrane and in restricted volumes of astrocyte processes on a timescale of seconds (Figs. 6–8).
We developed Lck-GCaMP2, a genetically targeted calcium sensor that is tethered to the plasma membrane, and used it to monitor distinct and previously unknown types of calcium signals in astrocytes, including signals localized in fine processes. In hippocampal astrocyte-neuron cocultures, Lck-GCaMP2 detected near membrane calcium signals evoked pharmacologically or by single action potential–mediated neurotransmitter release. Lck-GCaMP2 also revealed highly localized, frequent spontaneous calcium signals in astrocyte somata and processes that conventional GCaMP2 failed to detect. We used TIRF microscopy in our characterization experiments because it offers excellent axial resolution for studying signaling near the plasma membrane36. By necessity, we used cultured astrocytes, as TIRF can only be performed on cells that are attached to glass coverslips36. Although astrocytes in culture differ from those in vivo48, we believe that this does not detract from our finding that Lck-GCaMP2 is able to monitor calcium signaling near the plasma membrane and in fine processes of astrocytes.
The potential role of calcium signaling in distal astrocyte processes is important and understudied. Each hippocampal astrocyte may contact up to 100,000 synapses via its fine processes16. Calcium transients have mostly been measured from somatic regions of astrocytes. It remains unclear whether distal astrocyte processes have similar transients, whether calcium transients are compartmentalized or whether they are synchronous with the somatic regions. We attempted to measure differences between the soma and processes of astrocytes conventionally with Fluo-4 in acute hippocampal slices and found that calcium transients appeared to be compartmentalized in astrocyte branches (Supplementary Fig. 8). These observations are consistent with previously published work32,33 and support the hypothesis that local compartmentalized calcium transients exist in astrocyte branches. However, these and other data are limited because the volume of the astrocyte processes is too meager to adequately load with calcium indicator dyes, highlighting the need for alternative approaches, such as Lck-GCaMP2. It is noteworthy that the micro-domain calcium signals that we found in astrocyte processes using Lck-GCaMP2 are distinct from previous studies in Bergmann glia, which had microdomain-like signals as a result of calcium release from intracellular stores33. Thus, our finding of a membrane calcium flux pathway detected by Lck-GCaMP2 (Figs. 7 and and8)8) supports the emerging view that astroglia signal locally via their processes18.
Using cytosolic GCaMP2, we failed to detect spontaneous, presumably physiological, astrocyte calcium transients32. Although cytosolic GCaMP2 can detect pharmacologically evoked calcium signals, we believe such pharmacological GPCR-mediated signals are less interesting and probably represent nonphysiological activation of astrocytes. Using nearly simultaneous EPI and TIRF microscopy, we found that pharmacologically evoked signals were fundamentally different in terms of amplitude and spatial spread in relation to spontaneous calcium signals, which were smaller and more restricted. The possibility that pharmacologically evoked calcium signals may be nonphysiological has previously been raised15,29.
Our characterization and proof-of-principle experiments indicate that Lck-GCaMP2 is a substantial improvement over cytosolic GCaMP2 for detecting microdomain calcium signals in astrocytes. This approach can now be used to understand the settings in which calcium signals occur in individual astrocytes, which astrocytes display calcium signals in intact networks, and whether astrocyte processes generate calcium signals at their contact points with synapses and blood vessels. Our findings with membrane-targeted Lck-GCaMP2 do not detract from recent work using expression of the cytosolic FRET-based calcium sensor yellow cameleon 3.6 (YC3.6) in astrocytes49. However, cytosolic YC3.6 expression may be best suited to study astrocyte cell bodies, as astrocyte processes were revealed as a “hazy cloud.” Moreover, we believe our approach is simpler to implement, as Lck-GCaMP2 relies on a single wavelength for excitation (488 nm) and has a single emission peak (508 nm), making it ideal for standard single and multiphoton microscopes. Our data also suggest that, by virtue of the membrane tether, Lck-GCaMP2 is better suited to image calcium in fine processes. TIRF microscopy indicated that Lck-GCaMP2 was uniformly and predominantly expressed in the plasma membrane and was present at high levels in astrocyte processes that have a high plasma membrane–to-volume ratio. Finally, the restricted mobility of Lck-GCaMP2 renders it better suited to detecting local point source–like calcium signals that arise as a result of calcium entry across the plasma membrane50.
We found that Lck-GCaMP2 was efficiently targeted to the plasma membrane and functioned similar to native GCaMP2 in terms of calcium affinity and sensitivity39. To the best of our knowledge, the Lck domain has not previously been used to target a calcium sensor to the plasma membrane, although its membrane targeting ability has been reported41,42. Our data indicate that Lck efficiently recruited GCaMP2 to the plasma membrane, probably because it contains tandem palmitoylation and myristoylation domains. Fluorescent proteins are continually being improved by redesign and mutagenesis. Recent modification of GCaMP2 to GCaMP3 led to a threefold improved expression and signal-to-noise ratio that enabled tracking of spontaneous action potentials missed with GCaMP2 (ref. 43). In comparison, Lck-GCaMP2 improves near-surface expression in astrocytes by ~14-fold and improved the signal-to-noise ratio, resulting in the detection of spontaneous calcium signals not detected by cytosolic GCaMP2. In future studies, this Lck based strategy may be useful for determining the utility of new generations of genetically encoded calcium indicators.
The study of astrocyte calcium signaling and its potential effect on neuronal function is growing rapidly, but there are important unresolved issues. First, it is necessary to monitor astrocyte calcium signals in distal processes that contact synapses to test hypotheses on the role of astrocytes during synaptic transmission and plasticity15,27,29. Second, it is necessary to monitor calcium signaling in astrocyte endfeet near blood vessels and relate these to vessel constriction and/or dilation5,6. It will be important to extend our approach further by generating transgenic mice that express Lck-GCaMP2 selectively in astrocytes. Third, Lck-GCaMP2 will be useful to identify the molecular basis of calcium signals in astro-cytes using genome wide or targeted siRNA libraries. Technical advances often lead to breakthroughs in understanding complex problems; we believe that use of Lck-GCaMP2 in vitro and in vivo will reveal precisely how, when and where local calcium signaling occurs in astrocyte processes with relevance for astrocyte function, not only in healthy circuits, but also during reactive astrogliosis in specific injury and disease contexts3. Finally, Lck-GCaMP2 is likely to be useful for monitoring calcium signaling in other glial cells28 (oligodendrocytes, NG2 cells, Schwann cells, microglia), and thus add to the repertoire of available methods for exploring their roles in brain.
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
We thank L. Looger for a preprint of a manuscript on GCaMP3, A. Sagasti for the GCaMP2 plasmid, D.E. Bergles for insightful discussions and for the Lck domain plasmid, and M. Simon for MrgA1-EGFP. Our work was supported by the National Institutes of Health (NS060677 and NS057624), the Whitehall Foundation, a S&R Foundation Ryuji Ueno Award for Ion Channels or Barrier Function Research and a Stein-Oppenheimer Foundation Endowment Award (B.S.K.). E.S. was partly supported by the Uehara Memorial Foundation Fellowship of Japan.
Note: Supplementary information is available on the Nature Neuroscience website.
AUTHOR CONTRIBUTIONSE.S. carried out all of the imaging experiments. S.K. carried out all of the cloning experiments. All of the authors contributed to the writing of the manuscript. E.S. and B.S.K. constructed the figures. B.S.K. directed the research with feedback from M.V.S.
COMPETING FINANCIAL INTERESTS
The authors declare no competing financial interests.
Reprints and permissions information is available online at http://www.nature.com/reprintsandpermissions/.